Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26517 | 20370677 | Curr Pharm Des | Insulin resistance in nonalcoholic fatty liver disease. | 2010 | Details |
| A26520 | 20370672 | Curr Pharm Des | Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. | 2010 | Details |
| A26521 | 20370671 | Curr Pharm Des | Current and future therapeutic strategies in NAFLD. | 2010 | Details |
| A26522 | 20370670 | Curr Pharm Des | Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. | 2010 | Details |
| A26526 | 20037278 | Korean J Hepatol | Current status of liver disease in Korea: nonalcoholic fatty liver disease. | 2009 | Details |
| A26527 | 20361370 | Chirurg | [Indications and principles of metabolic surgery]. | 2010 | Details |
| A26529 | 20355234 | World J Gastroenterol | Liver fat content determined by magnetic resonance imaging and spectroscopy. | 2010 | Details |
| A26530 | 20355232 | World J Gastroenterol | Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials. | 2010 | Details |
| A26533 | 20347174 | J Hepatol | Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. | 2010 | Details |
| A26534 | 20308723 | Ann Hepatol | High ghrelin and obestatin levels and low risk of developing fatty liver. | 2010 | Details |
| A26535 | 20305757 | Hepatol Int | Fatty liver disease in children: eat now pay later. | 2010 | Details |
| A26537 | 20303728 | J Nutr Biochem | Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. | 2010 | Details |
| A26539 | 20301112 | Hepatology | Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26540 | 20300479 | Mediators Inflamm | Inflammatory mediators of hepatic steatosis. | 2010 | Details |
| A26541 | 20299294 | Prim Care Diabetes | Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? | 2010 | Details |
| A26542 | 20298493 | Acta Paediatr | Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound. | 2010 | Details |
| A26549 | 20222991 | Lipids Health Dis | NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26550 | 20222159 | World J Gastroenterol | Steatosis as a co-factor in chronic liver diseases. | 2010 | Details |
| A26552 | 20221393 | PLoS One | Role of alcohol metabolism in non-alcoholic steatohepatitis. | 2010 | Details |
| A26553 | 20216561 | Eur J Clin Nutr | Dietary and physical activity patterns in children with fatty liver. | 2010 | Details |
| A26554 | 20216079 | J Clin Gastroenterol | An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease. | 2010 | Details |
| A26558 | 20206411 | Gastroenterol Hepatol | [Obesity and liver disease]. | 2010 | Details |
| A26561 | 20204561 | AAPS J | Role of cannabinoids in the development of fatty liver (steatosis). | 2010 | Details |
| A26567 | 20196730 | Curr Mol Med | Non-invasive diagnostic tests for non-alcoholic fatty liver disease. | 2010 | Details |
| A26569 | 20195271 | Nat Rev Gastroenterol Hepatol | Pathology of nonalcoholic fatty liver disease. | 2010 | Details |
| A26572 | 20188144 | Biochim Biophys Acta | Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. | 2010 | Details |
| A26573 | 20186137 | Obesity (Silver Spring) | Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. | 2010 | Details |
| A26577 | 20179669 | Int J Obes (Lond) | Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. | 2010 | Details |
| A26581 | 20170634 | Biochem Biophys Res Commun | Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. | 2010 | Details |
| A26583 | 20165979 | Dig Dis Sci | Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
| A26584 | 20164781 | Eur J Gastroenterol Hepatol | The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. | 2010 | Details |
| A26586 | 20158939 | Proc Nutr Soc | Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. | 2010 | Details |
| A26589 | 20150538 | J Am Soc Nephrol | Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. | 2010 | Details |
| A26592 | 20142825 | Int J Obes (Lond) | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. | 2010 | Details |
| A26598 | 20119733 | Obes Surg | Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease. | 2010 | Details |
| A26599 | 20116951 | Eur J Radiol | Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy. | 2010 | Details |
| A26603 | 20111022 | Obesity (Silver Spring) | Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. | 2010 | Details |
| A26606 | 20101871 | Acta Clin Belg | Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics. | 2010 | Details |
| A26610 | 20096157 | Actas Dermosifiliogr | Cardiometabolic comorbidities and the approach to patients with psoriasis. | 2009 | Details |
| A26614 | 20091629 | Cochrane Database Syst Rev | Bariatric surgery for non-alcoholic steatohepatitis in obese patients. | 2010 | Details |
| A26615 | 20088867 | Liver Int | The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. | 2010 | Details |
| A26618 | 20085121 | Eur Rev Med Pharmacol Sci | Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. | 2010 | Details |
| A26619 | 20084525 | J Gastroenterol | Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. | 2010 | Details |
| A26620 | 20082871 | Arch Med Res | High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
| A26625 | 20078219 | Annu Rev Pathol | Nonalcoholic fatty liver disease: pathology and pathogenesis. | 2010 | Details |
| A26628 | 20066503 | Obes Surg | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. | 2010 | Details |
| A26629 | 20064693 | Med Hypotheses | Impact of ecology on development of NIDDM. | 2010 | Details |
| A26630 | 20064512 | Gastroenterology | SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. | 2010 | Details |
| A26635 | 20045153 | Metabolism | Plasma apelin levels in subjects with nonalcoholic fatty liver disease. | 2009 | Details |
| A26637 | 20043126 | Int J Mol Med | Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats. | 2010 | Details |
| A26640 | 25197507 | Middle East J Dig Dis | Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. | 2010 | Details |
| A26641 | 25197505 | Middle East J Dig Dis | The effect of weight reduction on ultrasonographic findings of nonalcoholic Fatty liver. | 2010 | Details |
| A26642 | 24149634 | J Sports Sci Med | Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. | 2010 | Details |
| A26646 | 21525763 | Dig Dis | Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis. | 2011 | Details |
| A26650 | 21442055 | Hepatol Int | Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. | 2010 | Details |
| A26651 | 21387764 | Przegl Lek | [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers]. | 2010 | Details |
| A26652 | 20041406 | Hepatology | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | 2010 | Details |
| A26653 | 20040915 | Am J Gastroenterol | Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". | 2009 | Details |
| A26656 | 20038265 | Immunopharmacol Immunotoxicol | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. | 2010 | Details |
| A26657 | 20036859 | Front Biosci (Elite Ed) | Biochemical characteristics and risk factors in non-alcoholic fatty liver. | 2010 | Details |
| A26659 | 20033348 | Obes Surg | SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. | 2009 | Details |
| A26664 | 20027672 | World J Gastroenterol | Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. | 2009 | Details |
| A26667 | 20022856 | Adv Med Sci | Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. | 2009 | Details |
| A26669 | 20022466 | Nutrition | Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. | 2009 | Details |
| A26674 | 20009132 | Ann Hepatol | Altered clot kinetics in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26676 | 20002471 | Diabet Med | Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. | 2009 | Details |
| A26684 | 19957147 | Methods Mol Biol | Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? | 2010 | Details |
| A26685 | 19957049 | Obes Surg | Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. | 2009 | Details |
| A26686 | 19956652 | PLoS One | Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice. | 2009 | Details |
| A26688 | 19948621 | Pediatrics | Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. | 2009 | Details |
| A26689 | 19948145 | Curr Biol | An emerging role of mTOR in lipid biosynthesis. | 2009 | Details |
| A26690 | 19947902 | Platelets | Mean platelet volume in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26694 | 19942238 | Metabolism | Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. | 2009 | Details |
| A26695 | 19942176 | Anesthesiol Clin | Surgery in the patient with liver disease. | 2009 | Details |
| A26697 | 19938136 | Liver Transpl | Posttransplant metabolic syndrome: an epidemic waiting to happen. | 2009 | Details |
| A26700 | 19934372 | Exp Biol Med (Maywood) | Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors. | 2009 | Details |
| A26706 | 19925500 | Aliment Pharmacol Ther | Review article: the management of hepatocellular carcinoma. | 2009 | Details |
| A26708 | 19923096 | Orv Hetil | [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease]. | 2009 | Details |
| A26709 | 19921118 | Adv Ther | Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. | 2009 | Details |
| A26711 | 19915460 | Curr Opin Lipidol | Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. | 2010 | Details |
| A26715 | 19912690 | Zhonghua Gan Zang Bing Za Zhi | [A hospital-based case-control study on influencing factors of nonalcoholic fatty liver disease]. | 2009 | Details |
| A26716 | 19911138 | World J Pediatr | Nonalcoholic fatty liver disease in children living in the obeseogenic society. | 2009 | Details |
| A26717 | 19910932 | Am J Hypertens | Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. | 2009 | Details |
| A26718 | 19908945 | J Immunotoxicol | Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. | 2009 | Details |
| A26719 | 19904291 | Eur J Clin Nutr | Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults. | 2009 | Details |
| A26722 | 19897197 | Atherosclerosis | Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. | 2009 | Details |
| A26724 | 19892897 | Postgrad Med J | The metabolic syndrome: common origins of a multifactorial disorder. | 2009 | Details |
| A26732 | 19882375 | J Gastroenterol | Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. | 2009 | Details |
| A26735 | 19878045 | Acta Odontol Scand | Relationship between periodontitis and hepatic abnormalities in young adults. | 2010 | Details |
| A26737 | 19875987 | Obesity (Silver Spring) | Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. | 2009 | Details |
| A26738 | 21160968 | World J Hepatol | Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. | 2009 | Details |
| A26739 | 19863497 | Aliment Pharmacol Ther | Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease. | 2009 | Details |
| A26740 | 19861959 | Am J Gastroenterol | Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. | 2009 | Details |
| A26743 | 19851063 | Ann Nutr Metab | Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection. | 2009 | Details |
| A26745 | 19847649 | Dig Dis Sci | The effects of a fat- and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male Wistar rats. | 2009 | Details |
| A26746 | 19845871 | Obes Rev | Non-alcoholic fatty liver disease from pathogenesis to management: an update. | 2009 | Details |
| A26747 | 19840251 | Liver Int | Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. | 2009 | Details |
| A26748 | 19840063 | Diabetes Obes Metab | The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. | 2009 | Details |
| A26749 | 19839225 | Br J Biomed Sci | Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity. | 2009 | Details |
| A26750 | 19834957 | Cancer | Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. | 2009 | Details |